92 related articles for article (PubMed ID: 3499181)
1. Spergualin: a new antitumour antibiotic.
Umezawa K; Takeuchi T
Biomed Pharmacother; 1987; 41(5):227-32. PubMed ID: 3499181
[TBL] [Abstract][Full Text] [Related]
2. [Spergualin, a new antitumor antibiotic].
Takeuchi T
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):845-9. PubMed ID: 3566295
[TBL] [Abstract][Full Text] [Related]
3. [Spergualin a novel antitumor antibiotic produced by Bacillus laterosporus].
Takeuchi T
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2633-9. PubMed ID: 6508320
[TBL] [Abstract][Full Text] [Related]
4. Involvement of cytotoxic T-lymphocytes in the antitumor activity of spergualin against L1210 cells.
Umezawa H; Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T
Cancer Res; 1987 Jun; 47(12):3062-5. PubMed ID: 3495325
[TBL] [Abstract][Full Text] [Related]
5. [Immunomodulation by antitumor antibiotics].
Ishizuka M
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
[TBL] [Abstract][Full Text] [Related]
6. Induction of antitumor resistance to mouse leukemia L1210 by spergualins.
Ishizuka M; Masuda T; Mizutani S; Osono M; Kumagai H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Dec; 39(12):1736-43. PubMed ID: 3546237
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of spergualin analogues. II. Chemical modification of the spermidine moiety.
Umeda Y; Moriguchi M; Kuroda H; Nakamura T; Fujii A; Iinuma H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1987 Sep; 40(9):1303-15. PubMed ID: 3680040
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of spergualin and amine oxidase activity in medium.
Kunimoto S; Miura K; Iinuma H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Jul; 38(7):899-903. PubMed ID: 4030503
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of (-)-15-deoxyspergualin and (-)-spergualin-15-phosphate.
Iwasawa H; Kondo S; Ikeda D; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1982 Dec; 35(12):1665-9. PubMed ID: 6926749
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of spergualin analogues. I. Chemical modification of 7-guanidino-3-hydroxyacyl moiety.
Umeda Y; Moriguchi M; Kuroda H; Nakamura T; Iinuma H; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Jul; 38(7):886-98. PubMed ID: 4030502
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of spergualin analogues. I.
Nishizawa R; Takei Y; Yoshida M; Tomiyoshi T; Saino T; Nishikawa K; Nemoto K; Takahashi K; Fujii A; Nakamura T
J Antibiot (Tokyo); 1988 Nov; 41(11):1629-43. PubMed ID: 3242505
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of spergualin, a novel antitumor antibiotic.
Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
[TBL] [Abstract][Full Text] [Related]
13. A new antitumor antibiotic, spergualin: isolation and antitumor activity.
Takeuchi T; Iinuma H; Kunimoto S; Masuda T; Ishizuka M; Takeuchi M; Hamada M; Naganawa H; Kondo S; Umezawa H
J Antibiot (Tokyo); 1981 Dec; 34(12):1619-21. PubMed ID: 7333976
[No Abstract] [Full Text] [Related]
14. Biological properties of 5,11-dimethyl-6H-pyrido[3,2-b]carbazoles: a new class of potent antitumour drugs.
Moinet-Hedin V; Tabka T; Poulain L; Godard T; Lechevrel M; Saturnino C; Lancelot JC; Le Talaër JY; Gauduchon P
Anticancer Drug Des; 2000 Apr; 15(2):109-18. PubMed ID: 10901298
[TBL] [Abstract][Full Text] [Related]
15. PNU 157977: a new potent antitumour agent exhibiting low in vivo toxicity in mice injected with L1210 leukaemia cells.
Baraldi PG; Balboni G; Romagnoli R; Spalluto G; Cozzi P; Geroni C; Mongelli N; Rutigliano C; Bianchi N; Gambari R
Anticancer Drug Des; 1999 Feb; 14(1):71-6. PubMed ID: 10363029
[TBL] [Abstract][Full Text] [Related]
16. The antiproliferative action of deoxyspergualin is different from that induced by amine oxidase.
Kuramochi H; Hiratsuka M; Nagamine S; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1988 Feb; 41(2):234-8. PubMed ID: 3356611
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E
Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382
[TBL] [Abstract][Full Text] [Related]
18. Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues.
Leopold WR; Shillis JL; Mertus AE; Nelson JM; Roberts BJ; Jackson RC
Cancer Res; 1984 May; 44(5):1928-32. PubMed ID: 6546897
[TBL] [Abstract][Full Text] [Related]
19. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
Ujiie T
Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
[TBL] [Abstract][Full Text] [Related]
20. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
